HUTCHMED (China) Ltd (FRA:H7T1)
€ 16.4 -0.7 (-4.09%) Market Cap: 2.80 Bil Enterprise Value: 2.13 Bil PE Ratio: 0 PB Ratio: 4.05 GF Score: 66/100

Half Year 2023 HUTCHMED (China) Ltd Earnings Call Transcript

Jul 31, 2023 / 12:00PM GMT
Release Date Price: €13.5 (+6.30%)
Operator

Good day, and thank you for standing by. Welcome to HUTCHMED 2023 Half Year Financial Results Presentation. (Operator Instructions) Please be advised that today's conference is being recorded.

I'd now like to hand the conference over to Mr. Mark Lee, Senior Vice President, Corporate Finance and Development of HUTCHMED. Please go ahead, sir.

Kin Hung Lee;China;Limited;SVP of Corporate Finance;Development
HUTCHMED

()-&

Thank you, Amber. Thank you, everybody, and welcome. At this time, I will remind you that the statements we have are forward-looking in nature and the results and operations of the HUTCHMED Group are historical in past performance. There's no guarantee of future results and that this presentation is intended for investors only and should be read in conjunction with the announcement we just made regarding the results for the 6 months ended June 30, 2023, and our various other filings in annual reports.

Now I'll hand you over to Dr. Wei-Guo Su, our Chief Executive

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot